A nurse is caring for a client who experienced a spontaneous abortion.
Which of the following findings should the nurse identify as the most common cause of spontaneous abortion?

Choice A rationale

Referral to a diabetes mellitus educator is not a standard or necessary part of hyperthyroidism management unless the client also has a concurrent diagnosis of diabetes. While both are endocrine disorders, their management strategies are entirely different. Hyperthyroidism focuses on regulating thyroid hormone production and cardiac symptoms, whereas diabetes focuses on glucose monitoring and insulin sensitivity. Therefore, this referral would be inappropriate and irrelevant for a client specifically seeking help for hyperthyroidism.

Choice B rationale

Management of hyperthyroidism during pregnancy is complex and requires specialized knowledge to balance maternal health with fetal safety. Endocrinologists are experts in hormonal regulation and are best equipped to manage medications like propylthiouracil or methimazole, which carry specific risks at different gestations. Collaborative care between the obstetrician and an endocrinologist ensures that thyroid levels are maintained in the high-normal range to avoid fetal hypothyroidism while preventing maternal thyrotoxicosis or thyroid storm.

Choice C rationale

Hyperthyroidism does not necessarily resolve after giving birth. In fact, many clients with Graves' disease may experience a significant flare-up or "rebound" of symptoms in the postpartum period as the immune system recovers from the pregnancy-induced state of suppression. While some temporary forms of gestational thyrotoxicosis might subside, true hyperthyroidism usually requires ongoing monitoring and treatment long after delivery. Assuming it will resolve spontaneously is scientifically inaccurate and potentially dangerous for the mother.

Choice D rationale

Monitoring thyroid-stimulating hormone (TSH) and free T4 levels twice per month is generally excessive for a stable client. The standard of care typically involves testing every 2 to 4 weeks initially, then moving to every 4 to 6 weeks once the client is euthyroid. Normal TSH levels in pregnancy are often lower than non-pregnant ranges (0.1 to 2.5 mIU/L in the first trimester). Over-testing can lead to unnecessary medication adjustments and does not follow standard clinical guidelines.

Choice A rationale

Pregnancy induces a hypercoagulable state as a physiological adaptation to prevent excessive hemorrhage during delivery. While clotting factors change significantly, an increase in the number and activation of platelets contributes to this heightened risk of venous thromboembolism. Platelet counts generally stay within the normal range of 150,000 to 450,000 per microliter, but their increased reactivity, combined with venous stasis and changes in coagulation proteins, makes pregnant individuals more susceptible to forming dangerous blood clots.

Choice B rationale

This statement is scientifically incorrect because natural anticoagulants, such as Protein S, actually decrease during pregnancy rather than increase. The reduction in these protective proteins is part of the body's shift toward hypercoagulability. If natural anticoagulants were to increase, the risk for blood clots would theoretically decrease. Because the body is preparing for the trauma of placental separation, it suppresses these anticoagulation mechanisms to ensure that clots can form quickly at the site of delivery.

Choice C rationale

Procoagulant factors, such as fibrinogen and factors VII, VIII, IX, and X, actually increase significantly during pregnancy to favor clot formation. A decrease in these factors would lead to a bleeding tendency rather than a clotting risk. Fibrinogen levels, for example, can rise to 400 to 600 mg/dL, well above the non-pregnant range of 200 to 400 mg/dL. These elevated levels are necessary to manage the hemostatic challenges of childbirth but increase the baseline risk for thrombosis.

Choice D rationale

While blood plasma volume does increase by approximately 40 to 50 percent during pregnancy, this expansion primarily causes physiological anemia of pregnancy rather than directly causing blood clots. The increase in volume is a compensatory mechanism to ensure adequate perfusion to the placenta and to provide a reserve for blood loss during birth. While it affects hemodynamics, the actual mechanism of increased clotting risk is driven by the biochemical changes in clotting factors and platelets.